Ghent University – Developmental Therapeutics Review – Q1 2011

Date: March 1, 2011
Pages: 34
Price:
US$ 500.00 US$ 450.00
Offer valid until December 31, 2014!
License [?]:
Publisher: Global Markets Direct
Report type: Brief Review
Delivery: E-mail Delivery (PDF)
ID: GB6535B0806EN
Leaflet:

Download PDF Leaflet

Ghent University - Developmental Therapeutics Review - Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Ghent University Hospital - Developmental Therapeutics Review - Q1 2011” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope
  • Review of therapeutics under development by Ghent University Hospital.
  • Overview of products under development across various therapy areas.
  • Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Ghent University Hospital with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of Ghent University Hospital’s therapeutic products in the last quarter.
  • Latest news and deals relating to the products.
Reasons to buy
  • Identify new drug targets and therapeutic classes in Ghent University Hospital’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
  • Evaluate Ghent University Hospital’s position with total access to a detailed information on its therapeutic products development.
  • Assess the growth potential of Ghent University Hospital in its therapy areas of focus.
  • Exploit collaboration and partnership opportunities with Ghent University Hospital.
  • Avoid Intellectual Property Rights related issues.
Table of Contents
List of Tables
List of Figures
Ghent University Snapshot
Ghent University Overview
Key Information
Key Facts
Ghent University – Research and Development Overview
Key Therapeutic Areas
Ghent University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Ghent University – Pipeline Products Glance
Ghent University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Ghent University – Drug Profiles
Methylprednisolone
Product Description
Mechanism of Action
R&D Progress
rituximab + methylprednisolone
Product Description
Mechanism of Action
R&D Progress
Ghent University – Pipeline Analysis
Ghent University – Pipeline Products by Therapeutic Class
Ghent University - Pipeline Products By Target
Ghent University – Pipeline Products by Molecule Type
Ghent University - Dormant Projects
Ghent University – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Ghent University, Deals Volume Summary, 2004 to YTD 2011
Ghent University, Deals Summary By Region, 2004 to YTD 2011
Ghent University, Deals Summary, 2004 to YTD 2011
Ghent University Detailed Deal Summary
Venture Financing
Pronota Secures Additional $1.92 Million In Series B Round Of Financing
ActoGeniX Secures $20 Million In Venture Financing
ActoGeniX Secures Additional $11 Million In Series A Financing
Pronota Secures $18.4 Million In Series A Financing
Equity Offering
SM Prime Holdings plans for equity offering of $300 million
Licensing Agreements
Hybrigenics Enters Into Worldwide Licensing Agreement With Ghent University, Katholieke Universiteitn And THERAMEX
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Ghent University – Pipeline by Therapy Area and Indication, 2011
Ghent University – Pipeline by Stage of Development, 2011
Ghent University – Monotherapy Products in Pipeline, 2011
Ghent University – Combination Treatment Modalities in Pipeline, 2011
Ghent University - Phase II, 2011
Ghent University - Pipeline By Therapeutic Class, 2011
Ghent University - Pipeline By Target, 2011
Ghent University – Pipeline By Molecule Type, 2011
Ghent University - Dormant Developmental Projects, 2010
Ghent University, Deals Summary, 2004 to YTD 2011
Ghent University, Deals Summary by Region, 2004 to YTD 2011
Ghent University, Deals Summary, 2004 to YTD 2011

LIST OF FIGURES

Ghent University – Pipeline by Therapy Area and Indication, 2011
Ghent University – Pipeline by Stage of Development, 2011
Ghent University – Monotherapy Products in Pipeline, 2011
Ghent University – Combination Treatment Modalities in Pipeline, 2011
Ghent University – Pipeline By Therapeutic Class, 2011
Ghent University – Pipeline By Molecule Type, 2011

Ask Your Question

Ghent University – Developmental Therapeutics Review – Q1 2011
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: